© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Dermatology
Kim Kjoller, MD: BLA for Tralokinumab and the Next Steps
July 31, 2020
Video
The FDA will be working over the next few months to ensure tralokinumab is efficient for atopic dermatitis.
Kim Kjoller, MD: Comparing Tralokinumab to Other Agents for Atopic Dermatitis
July 31, 2020
Video
An expert explains differences between tralokinumab and other popular agents for atopic dermatitis.
FDA Expands Ustekinumab to Pediatric Plaque Psoriasis
July 31, 2020
Article
The expansion makes history for the injection biologic.
Kim Kjoller, MD: Results of Tralokinumab Trials
July 24, 2020
Video
Kim Kjøller, MD, breaks down the findings from ECZTRA1, 2, and 3.
Kim Kjoller, MD: Tralokinumab for Atopic Dermatitis
July 24, 2020
Video
Kim Kjøller, MD, discusses how tralokinumab can be used for the treatment of atopic dermatitis.
Upadacitinib Demonstrates Safety and Efficacy for Atopic Dermatitis
July 21, 2020
Article
Upadacitinib 15 mg and 30 mg outperformed placebo in Measure Up 2, the second part of a phase 3 study on the monotherapy.
Likelihood of Enanthem Among COVID-19 Patients with Skin Rash
July 16, 2020
Article
Of the 21 patients included in the study with COVID-19 and skin rash, 29% had enanthem.
Barriers Prevent Pediatricians from Implementing Peanut Allergy Guidelines
July 15, 2020
Article
Although a majority of pediatricians are aware of the guidelines, less than one-third of survey respondents report full implementation.
FDA Approves Guselkumab for Active Psoriatic Arthritis
July 14, 2020
Article
Guselkumab represents the first FDA approved medication for active psoriatic arthritis that selectively inhibits interleukin-23.
FDA Issues Complete Response Letter for VP-102 for Molluscum
July 14, 2020
Article
The FDA is looking for more information regarding aspects of the chemistry, manufacturing, and controls process for the drug-device combination